Ashwlayan Vrish Dhwaj, Ratnesh Ratneshwar Kumar, Sharma Divya, Sharma Alok, Sangal Akansha, Saifi Alimuddin, Singh Jay
Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, U.P. 250005 India.
Department of Electronics and Communication Engineering, Meerut Institute of Engineering and Technology, Meerut, U.P. 250005 India.
Indian J Microbiol. 2025 Mar;65(1):15-31. doi: 10.1007/s12088-024-01265-y. Epub 2024 Apr 10.
Gastrointestinal impairment induced sleep, behavioral and psychiatric disorders were reported in patients of autism spectrum disorders (ASDs). These may be life-long neuro-developmental disorders. Standardized diagnostic criteria for ASDs include: restricted and repetitive behavior, ongoing deficiencies in social interaction and communication. Proantioxidant and anti-inflammatory effects of dietry polyphenols/poly-phenol-rich derivatives as bioactive compounds enhanced permeability of blood brain barrier, consequently leads to delay in the onset of ASDs symptoms and can be effectively used in the management of ASDs. During the research on ASDs numerous therapeutic modalities, such as chemical and plant-based therapies, have been investigated. Due to their possible neuro-psychopharmacological benefits, plant-based treatments have attracted interest. These natural source therapies have demonstrated potential in reducing ASDs-related symptoms. Plant-based psycho-pharmaceuticals have been thoroughly investigated, and the investigations have confirmed their therapeutic effects. The therapeutic qualities of plants not only address the complex neurological aspects of ASDs but also provide a comprehensive approach to treatment. These substances may restore neurochemical equilibrium by focusing on particular biochemical pathways associated with the illness. Advancements in pharmacology and neurochemistry have enabled targeted interventions through chemical approaches. The treatment of ASDs approached through a combination of plant-based solutions and chemical methods can be better than one alone. By targeting the restorative properties of both natural compounds and synthesized chemicals, researchers aim to address the diverse range of symptoms and underlying neurobiological abnormalities associated with ASDs. Further clinical studies are required to validate the potential of bioactive molecules scientifically.
据报道,自闭症谱系障碍(ASD)患者存在胃肠道功能损害引发的睡眠、行为和精神障碍。这些可能是终身性的神经发育障碍。ASD的标准化诊断标准包括:受限和重复行为、社交互动和沟通方面持续存在缺陷。作为生物活性化合物的膳食多酚/富含多酚的衍生物的抗氧化和抗炎作用增强了血脑屏障的通透性,从而导致ASD症状的发作延迟,并可有效用于ASD的管理。在对ASD的研究过程中,已经研究了多种治疗方式,如化学疗法和植物疗法。由于其可能的神经心理药理学益处,植物疗法引起了人们的兴趣。这些天然来源的疗法已显示出减轻ASD相关症状的潜力。基于植物的精神药物已得到充分研究,研究证实了它们的治疗效果。植物的治疗特性不仅解决了ASD复杂的神经学问题,还提供了一种全面的治疗方法。这些物质可能通过关注与该疾病相关的特定生化途径来恢复神经化学平衡。药理学和神经化学的进展使得通过化学方法进行靶向干预成为可能。通过结合基于植物的解决方案和化学方法来治疗ASD可能比单独使用一种方法更好。通过针对天然化合物和合成化学物质的恢复特性,研究人员旨在解决与ASD相关的各种症状和潜在的神经生物学异常。需要进一步的临床研究来科学地验证生物活性分子的潜力。